Drug Name: Bimzelx Active Ingredient: bimekizumab Indication: To treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy Approval Date: 10/17/2023 Company: UCB, Inc…
Drug Name: Sotyktu Active Ingredient: deucravacitinib Indications: To treat moderate-to-severe plaque psoriasis Approval Date: 9/9/2022 Company: Bristol-Myers Squibb Company Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214958s000lbl.pdf
Drug Name: Vtama Active Ingredient: tapinarof Indications: To treat plaque psoriasis Approval Date: 5/23/2022 Company: Dermavant Sciences Inc, Dermavant Sciences, GmbH Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215272s000lbl.pdf